Verification of the efficacy of collagen peptide for the purpose of flail-Locomotive Syndrome Prevention

Verification of the efficacy of collagen peptide for the purpose of flail-Locomotive Syndrome Prevention - Effect of collagen peptide intake for the purpose of locomotive syndrome prevention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023388

Enrollment

Registered

2016-07-31

Start date

2016-07-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person who aware of the initial knee joint pain

Interventions

Intervention: Intake 2.5g collagen peptide for 120 days Control: Intake 2.5g whey for 120 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Who diagnosed with ever knee osteoarthritis, who are undergoing treatment. Who has been found gelatin allergy. Who is known dairy allergy.

Exclusion criteria

Exclusion criteria: Who diagnosed with ever knee osteoarthritis, who are undergoing treatment. Who has been found gelatin allergy. Who is known dairy allergy.

Design outcomes

Primary

Measure	Time frame
The extent of the knee joint pain in the VAS score	—

Secondary

Measure	Time frame
Impact muscle mass / visceral fat area in the exercise-associated, dominant arm of grip strength, eye-opening one leg Standing time, bone density, pulse wave velocity, and KSS score.	—

Countries

Japan

Contacts

Public ContactIgase Michiya

Ehime University Department of Geriatrics and Neurology, Ehime University Graduate School of Medicine

migase@m.ehime-u.ac.jp089-960-5851

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026